IL17A and infection: To begin addressing the potential contributions of lymphocytes to the host defense upon infection with the fbp1Δ mutant, we treated IL-17A−/− mice with neutralizing antibodies to IFN-γ to target the main effector cytokines of Th1 and Th17 cells.